Strategies to enhance virtual care through quality assurance frameworks, technological innovation, and provider support were ...

Trethera Corporation (“Trethera”), a clinical stage biopharmaceutical company committed to targeting cancer and autoimmune ...

Lead program investigating MT-601 in patients with refractory lymphomas, including anti-CD19 CAR-T cell therapy, demonstrated safety and efficacy in 9 patients with 78% having objective responses, inc ...

The company reported a net loss attributable to common stockholders of $4.1 million, or $0.27 per share, for the three months ended December 31, 2024, compared to a net loss attributable to common ...

The median operating margin for providers that ended their fiscal years early was 1.2% last year, compared with -0.5% in 2023 ...

VIKTORIA-2 Phase 3 remains on track to enroll its first patient in Q2 2025 Presented encouraging preliminary overall survival ...

Q4 2024 Management View CEO Jim Dentzer highlighted significant progress in their TakeAim Lymphoma study, which evaluates the combination of emavusertib and ibrutinib in primary central nervous system ...

MZE829 Phase 2 HORIZON Trial Enrolling Patients with APOL1 Kidney Disease (AKD); Initial Data Expected in Q1 2026MZE782 Phase 1 Healthy Volunteer ...

BEIJING, CHINA / ACCESS Newswire / March 31, 2025 / CASI Pharmaceuticals, Inc. (NASDAQ:CASI), ("CASI" or the "Company"), a Cayman incorporated biopharmaceutical company focused on developing and ...

London Lamar (D-Memphis) is hoping to deliver this year with a state ban on “Glock switches” and machine gun conversion kits. These devices allow semi-automatic firearms to function as an illegal, ...

A new report from the Private Equity Stakeholder Project reveals that private equity firms have been increasingly acquiring ...

Half a century after the state tightened the criteria for involuntary commitment, Gov. Kathy Hochul wants to make it easier to hospitalize mentally ill people against their will.